The MRDR had the opportunity to for two poster presentations at the International Myeloma Society Annual meeting in Athens.
The MRDR reaches another milestone of recruiting more than 6500 patients!
Please join us for our annual Interest Group breakfast at Blood 2023, 6th November.
MY-PROMPT-2 project randomises first patient and enrols another!
Ken Lim's paper on Inferior outcomes in t(11;14) multiple myeloma has been accepted for publication.
Congratulations on recruiting >6000 patients on the MRDR!!!
Paper on the second revision of the International Staging System (R2-ISS) accepted for publication!